{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:10:26Z","timestamp":1786374626864,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Project of the Joint Fund for Science and Technology Innovation of Fujian Province","award":["2024Y9049"],"award-info":[{"award-number":["2024Y9049"]}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2023J011188"],"award-info":[{"award-number":["2023J011188"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2024J011032"],"award-info":[{"award-number":["2024J011032"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Intenal Supporting Project of Fuzhou University Affiliated Provincial Hospital","award":["0080072231"],"award-info":[{"award-number":["0080072231"]}]},{"name":"Intenal Supporting Project of Fuzhou University Affiliated Provincial Hospital","award":["0080072220"],"award-info":[{"award-number":["0080072220"]}]},{"name":"the Special Project of Major Science and Technology Projects of Fujian Province","award":["2022NZ029017"],"award-info":[{"award-number":["2022NZ029017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-026-08678-9","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T02:15:47Z","timestamp":1779675347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Drug-associated oropharyngeal infection: a real-world pharmacovigilance study using the FDA adverse event reporting system database"],"prefix":"10.1186","volume":"26","author":[{"given":"Chengyang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyuan","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junshan","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"issue":"2","key":"8678_CR1","doi-asserted-by":"publisher","first-page":"164","DOI":"10.15690\/pf.v22i2.2897","volume":"22","author":"NA Dayhes","year":"2025","unstructured":"Dayhes NA, Baranov AA, Lobzin YV, Namazova-Baranova LS, Kozlov RS, Polyakov DP, Karneeva OV, Gurov AV, Tulupov DA, Ryazantsev SV, Garashchenko TI, Kim IA, Andreeva IV, Bakradze MD, Polyakova AS, Vishneva EA, Selimzyanova LR, Tatochenko VK, Kulichenko TV. Modern Clinical Guidelines for the Management of Patients with Acute Tonsillitis and Pharyngitis. Pediatr Pharmacol. 2025;22(2):164\u201377.","journal-title":"Pediatr Pharmacol"},{"key":"8678_CR2","doi-asserted-by":"crossref","unstructured":"Reis CSM, Reis JGC, Concei\u00e7\u00e3o-Silva F, Valete CM. Oral and oropharyngeal mucosal lesions: clinical-epidemiological study of patients attended at a reference center for infectious diseases. Braz J Otorhinolaryngol. 2024 May-Jun;90(3):101396.","DOI":"10.1016\/j.bjorl.2024.101396"},{"issue":"1","key":"8678_CR3","doi-asserted-by":"publisher","first-page":"101459","DOI":"10.1016\/j.mycmed.2023.101459","volume":"34","author":"VAQ Freitas","year":"2024","unstructured":"Freitas VAQ, Santos AS, Zara ALSA, da Costa RA, Barreto CC, Soares RBA, Godoy CSM, Silva MDRR. Lodderomyces elongisporus as causative organism of oropharyngeal infections - Two case reports. J Mycol Med. 2024;34(1):101459.","journal-title":"J Mycol Med"},{"issue":"1","key":"8678_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41572-024-00503-3","volume":"10","author":"C Lass-Fl\u00f6rl","year":"2024","unstructured":"Lass-Fl\u00f6rl C, Kanj SS, Govender NP, Thompson GR 3rd, Ostrosky-Zeichner L, Govrins MA. Invasive candidiasis. Nat Rev Dis Primers. 2024;10(1):20.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"8678_CR5","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.56609\/jac.v43i2.550","volume":"43","author":"P Faccioni","year":"2025","unstructured":"Faccioni P, Montagna P, Colapinto G, Zangani A, Melloni F, Di Cosola M, et al. Oral Candidiasis: Manifestations, Treatment and Management in Immunocompromised Patients. J Appl Cosmetology. 2025;43(2):3744.","journal-title":"J Appl Cosmetology"},{"issue":"7","key":"8678_CR6","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","volume":"24","author":"DW Denning","year":"2024","unstructured":"Denning DW. Global incidence and mortality of severe fungal disease. Lancet Infect Dis. 2024;24(7):e428\u201338.","journal-title":"Lancet Infect Dis"},{"key":"8678_CR7","doi-asserted-by":"publisher","first-page":"103031","DOI":"10.1016\/j.ctim.2024.103031","volume":"81","author":"R B\u00fcttner","year":"2024","unstructured":"B\u00fcttner R, Schwermer M, Ostermann T, L\u00e4ngler A, Zuzak T. Expert consensus-based clinical recommendation for an integrative anthroposophic treatment approach to acute tonsillitis in childhood. Complement Ther Med. 2024;81:103031.","journal-title":"Complement Ther Med"},{"issue":"5","key":"8678_CR8","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3390\/pathogens13050426","volume":"13","author":"KM Thambugala","year":"2024","unstructured":"Thambugala KM, Daranagama DA, Tennakoon DS, Jayatunga DPW, Hongsanan S, Xie N. Humans vs. Fungi: An Overview of Fungal Pathogens against Humans. Pathogens. 2024;13(5):426.","journal-title":"Pathogens"},{"key":"8678_CR9","doi-asserted-by":"publisher","first-page":"1661524","DOI":"10.3389\/froh.2025.1661524","volume":"6","author":"KM Czajka","year":"2025","unstructured":"Czajka KM, Verschoor CP, Santi SA, Brabant-Kirwan D, Kusnierczyk MH, Venkataraman K, Appanna VD, Singh R, Tharmalingam S, Saunders DP. Signs and symptoms of oral candidiasis associated with health factors and resistant Candida infections in a Northern Ontario patient cohort. Front Oral Health. 2025;6:1661524.","journal-title":"Front Oral Health"},{"issue":"21","key":"8678_CR10","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.3390\/jcm14217537","volume":"14","author":"T Hirai","year":"2025","unstructured":"Hirai T, Nashi M. Pharmacological Management of Oral and Esophageal Candidiasis: A Clinical Pharmacotherapy Perspective [J]. J Clin Med. 2025;14(21):7537.","journal-title":"J Clin Med"},{"issue":"4","key":"8678_CR11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3390\/jof7040290","volume":"7","author":"G Ingrosso","year":"2021","unstructured":"Ingrosso G, Saldi S, Marani S, Wong AYW, Bertelli M, Aristei C, Zelante T. Breakdown of Symbiosis in Radiation-Induced Oral Mucositis. J Fungi (Basel). 2021;7(4):290.","journal-title":"J Fungi (Basel)"},{"issue":"3","key":"8678_CR12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jaad.2023.05.041","volume":"89","author":"D Arcuri","year":"2023","unstructured":"Arcuri D, Kaouache M, Lagac\u00e9 F, Sasseville D, Litvinov I. A case-control pharmacovigilance study of TNF-alpha inhibitors and interleukin inhibitors on tuberculosis, Candida, lymphoma and suicidality using the FAERS database (2014\u20132020). J Am Acad Dermatol. 2023;89(3):619\u201321.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"8678_CR13","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3390\/pathogens13121084","volume":"13","author":"PE Murray","year":"2024","unstructured":"Murray PE, Coffman JA, Garcia-Godoy F. Oral Pathogens\u2019 Substantial Burden on Cancer, Cardiovascular Diseases, Alzheimer\u2019s, Diabetes, and Other Systemic Diseases: A Public Health Crisis-A Comprehensive Review. Pathogens. 2024;13(12):1084.","journal-title":"Pathogens"},{"issue":"6","key":"8678_CR14","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s11096-022-01472-x","volume":"44","author":"JJ Chen","year":"2022","unstructured":"Chen JJ, Huo XC, Wang SX, Wang F, Zhao Q. Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system. Int J Clin Pharm. 2022;44(6):1351\u201360.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"8678_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40360-023-00657-y","volume":"24","author":"HS Ahdi","year":"2023","unstructured":"Ahdi HS, Wichelmann TA, Pandravada S, Ehrenpreis ED. Medication-induced osteonecrosis of the jaw: a review of cases from the Food and Drug Administration Adverse Event Reporting System (FAERS). BMC Pharmacol Toxicol. 2023;24(1):15.","journal-title":"BMC Pharmacol Toxicol"},{"key":"8678_CR16","doi-asserted-by":"publisher","first-page":"1231320","DOI":"10.3389\/fphar.2023.1231320","volume":"14","author":"L Zhang","year":"2023","unstructured":"Zhang L, Mao W, Liu D, et al. Risk factors for drug-related acute pancreatitis: an analysis of the FDA adverse event reporting system (FAERS). Front Pharmacol. 2023;14:1231320. Published 2023 Nov 17.","journal-title":"Front Pharmacol"},{"key":"8678_CR17","doi-asserted-by":"publisher","first-page":"105093","DOI":"10.1016\/j.oraloncology.2020.105093","volume":"112","author":"AL Mazul","year":"2021","unstructured":"Mazul AL, Naik AN, Zhan KY, Stepan KO, Old MO, Kang SY, Nakken ER, Puram SV. Gender and race interact to influence survival disparities in head and neck cancer. Oral Oncol. 2021;112:105093.","journal-title":"Oral Oncol"},{"issue":"2","key":"8678_CR18","first-page":"25","volume":"55","author":"G Daug\u0117lait\u0117","year":"2019","unstructured":"Daug\u0117lait\u0117 G, U\u017ekuraityt\u0117 K, Jagelavi\u010dien\u0117 E, Filipauskas A. Prevention and Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis. Med (Kaunas). 2019;55(2):25.","journal-title":"Med (Kaunas)"},{"key":"8678_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.oraloncology.2019.05.009","volume":"94","author":"L Benchetrit","year":"2019","unstructured":"Benchetrit L, Torabi SJ, Tate JP, Mehra S, Osborn HA, Young MR, Burtness B, Judson BL. Gender disparities in head and neck cancer chemotherapy clinical trials participation and treatment. Oral Oncol. 2019;94:32\u201340.","journal-title":"Oral Oncol"},{"issue":"16suppl","key":"8678_CR20","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.1200\/JCO.2022.40.16_suppl.6049","volume":"40","author":"N Ossazuwa-Peters","year":"2022","unstructured":"Ossazuwa-Peters N, Abouelella DK, Bhardwaj A, Patel AM, Hussaini AS, Seetharaman K, et al. Racial disparity in receipt of immunotherapy treatment among elderly patients with head and neck cancer. J Clin Oncol. 2022;40(16suppl):6049\u20136049.","journal-title":"J Clin Oncol"},{"issue":"2","key":"8678_CR21","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/all.14870","volume":"77","author":"T Miyano","year":"2022","unstructured":"Miyano T, Irvine AD, Tanaka RJ. A mathematical model to identify optimal combinations of drug targets for dupilumab poor responders in atopic dermatitis. Allergy. 2022;77(2):582\u201394.","journal-title":"Allergy"},{"key":"8678_CR22","doi-asserted-by":"crossref","unstructured":"Bulek K, Swaidani S, Aronica M, Li X. Epithelium: the interplay between innate and Th2 immunity. Immunol Cell Biol 2010 Mar-Apr;88(3):257\u201368.","DOI":"10.1038\/icb.2009.113"},{"issue":"5","key":"8678_CR23","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3390\/biomedicines11051444","volume":"11","author":"SM Tugizov","year":"2023","unstructured":"Tugizov SM. Molecular Pathogenesis of Human Immunodeficiency Virus-Associated Disease of Oropharyngeal Mucosal Epithelium. Biomedicines. 2023;11(5):1444.","journal-title":"Biomedicines"},{"issue":"1","key":"8678_CR24","doi-asserted-by":"publisher","first-page":"12411","DOI":"10.1038\/s41598-023-39311-2","volume":"13","author":"L Zhang","year":"2023","unstructured":"Zhang L, Ding Y, Wang Q, Pan W, Wei Z, Smith PA, Yang X. Preclinical immunological characterization of rademikibart (CBP\u2013201), a next-generation human monoclonal antibody targeting IL\u20134R\u03b1, for the treatment of Th2 inflammatory diseases. Sci Rep. 2023;13(1):12411.","journal-title":"Sci Rep"},{"key":"8678_CR25","doi-asserted-by":"publisher","first-page":"112441","DOI":"10.1016\/j.colsurfb.2022.112441","volume":"213","author":"L Wang","year":"2022","unstructured":"Wang L, Cao Y, Zhang X, Liu C, Yin J, Kuang L, He W, Hua D. Reactive oxygen species-responsive nanodrug of natural crocin-i with prolonged circulation for effective radioprotection. Colloids Surf B Biointerfaces. 2022;213:112441.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"8678_CR26","doi-asserted-by":"publisher","first-page":"103296","DOI":"10.1016\/j.critrevonc.2021.103296","volume":"160","author":"D Enrico","year":"2021","unstructured":"Enrico D, Waisberg F, Burton J, Mand\u00f3 P, Chac\u00f3n M. Analysis of adverse events attribution and reporting in cancer clinical trials: A systematic review. Crit Rev Oncol Hematol. 2021;160:103296.","journal-title":"Crit Rev Oncol Hematol"},{"key":"8678_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.radonc.2021.07.004","volume":"162","author":"SH Jeon","year":"2021","unstructured":"Jeon SH, Lim YJ, Koh J, Chang WI, Kim S, Kim K, Chie EK. A radiomic signature model to predict the chemoradiation-induced alteration in tumor-infiltrating CD8\u2009+\u2009cells in locally advanced rectal cancer. Radiother Oncol. 2021;162:124\u201331.","journal-title":"Radiother Oncol"},{"key":"8678_CR28","doi-asserted-by":"publisher","first-page":"1609409","DOI":"10.3389\/fcimb.2025.1609409","volume":"15","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Wang Y, Feng Y, Zhang H, Sun T, Xu J. Real-world pharmacovigilance reports of hepatitis A inactivated and hepatitis B (recombinant) vaccine: insights from disproportionality analysis of the vaccine adverse event reporting system. Front Cell Infect Microbiol. 2025;15:1609409.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"8678_CR29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12911-019-0999-1","volume":"19","author":"R Liu","year":"2019","unstructured":"Liu R, Zhang P. Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports. BMC Med Inf Decis Mak. 2019;19(1):279.","journal-title":"BMC Med Inf Decis Mak"},{"issue":"8","key":"8678_CR30","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1093\/aje\/kwac035","volume":"191","author":"JJ Yland","year":"2022","unstructured":"Yland JJ, Wesselink AK, Lash TL, Fox MP. Misconceptions About the Direction of Bias From Nondifferential Misclassification. Am J Epidemiol. 2022;191(8):1485\u201395. https:\/\/doi.org\/10.1093\/aje\/kwac035.","journal-title":"Am J Epidemiol"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-026-08678-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08678-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08678-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:03:30Z","timestamp":1786370610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12903-026-08678-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8678"],"URL":"https:\/\/doi.org\/10.1186\/s12903-026-08678-9","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1398"}}